array(3) { ["company_details"]=> array(13) { ["name"]=> string(27) "Tekla World Healthcare Fund" ["slug"]=> string(36) "b56a5-us-tekla-world-healthcare-fund" ["logo"]=> NULL ["description"]=> string(834) "Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website." ["address_street"]=> string(20) "100 Federal St FL 19" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2015-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(57) "https://www.teklacap.com/funds/thw/info/fund-information/" ["industry_codes"]=> array(1) { [0]=> string(101) "Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices" } ["employee_count"]=> int(3) ["article_count"]=> int(154) } ["articles"]=> array(2) { [0]=> array(7) { ["title_en"]=> string(70) "Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc." ["snippet_en"]=> string(190) "Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds." ["url"]=> string(118) "https://www.nasdaq.com/press-release/tekla-funds-approve-new-investment-advisory-agreements-with-abrdn-inc.-2023-10-27" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-06-30" ["categories"]=> array(5) { [0]=> string(19) "Investment Requests" [1]=> string(13) "Collaboration" [2]=> string(18) "General Investment" [3]=> string(15) "Deals & Tenders" [4]=> string(25) "Business Model Resilience" } } [1]=> array(7) { ["title_en"]=> string(59) "Tekla Capital Management LLC Announces Proposed Transaction" ["snippet_en"]=> string(290) "BOSTON, June 20, 2023--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn in assets under management.1" ["url"]=> string(84) "https://finance.yahoo.com/news/tekla-capital-management-llc-announces-214800997.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/27f9210f-e79b-418d-a9ec-eb1db0a63f25" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-06-20" ["categories"]=> array(2) { [0]=> string(15) "Deals & Tenders" [1]=> string(13) "Collaboration" } } } ["category_annotations"]=> array(25) { [0]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(18) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(14) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(9) } [3]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } [4]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [6]=> array(2) { ["name"]=> string(18) "Business Structure" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(3) } [8]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(3) } [9]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(5) "Debts" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(17) "Commodity Pricing" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } } } b56a5-us-tekla-world-healthcare-fund